サクサク読めて、アプリ限定の機能も多数！
トップへ戻る
衆院選
www.cdc.gov
Physical activity is anything that gets your body moving. Each week adults need 150 minutes of moderate-intensity physical activity and 2 days of muscle strengthening activity, according to the current Physical Activity Guidelines for Americans. We know 150 minutes of physical activity each week sounds like a lot, but you don’t have to do it all at once. It could be 30 minutes a day, 5 days a week
Long COVIDSome people who have been infected with the virus that causes COVID-19 can experience long-term effects from their infection, known as Long COVID or Post-COVID Conditions (PCC). Long COVID is broadly defined as signs, symptoms, and conditions that continue or develop after acute COVID-19 infection. This definition of Long COVID was developed by the Department of Health and Human Services
The use of face masks or respirators (N95/KN95) is recommended to reduce transmission of SARS-CoV-2, the virus that causes COVID-19 (1). Well-fitting face masks and respirators effectively filter virus-sized particles in laboratory conditions (2,3), though few studies have assessed their real-world effectiveness in preventing acquisition of SARS-CoV-2 infection (4). A test-negative design case-con
During July 2021, 469 cases of COVID-19 associated with multiple summer events and large public gatherings in a town in Barnstable County, Massachusetts, were identified among Massachusetts residents; vaccination coverage among eligible Massachusetts residents was 69%. Approximately three quarters (346; 74%) of cases occurred in fully vaccinated persons (those who had completed a 2-dose course of
Statement from CDC Director Rochelle P. Walensky, MD, MPH on Today’s MMWR On July 27th, CDC updated its guidance for fully vaccinated people, recommending that everyone wear a mask in indoor public settings in areas of substantial and high transmission, regardless of vaccination status. This decision was made with the data and science available to CDC at the time, including a valuable public healt
CDC’s Laboratory Outreach Communication System (LOCS)CDC’s gateway to engage with the laboratory and testing community
Recommendations for the use of 2024–2025 Novavax COVID-19 Vaccine in people ages 12 years and older Updated guidance in the Interchangeability of COVID-19 vaccines section and in Appendix B on completion of an initial vaccination series if vaccine doses from different manufacturers are administered in certain circumstances
Persons Aged 6 Months – 4 Years Local Reactions Local reactions were reported by half (48%) of vaccine recipients and at higher rates than placebo recipients. Vaccine recipients reported similar rates of local reactions after dose 1 and dose 2, but slightly lower after dose 3. Pain/tenderness at the injection site was the most frequent and severe reported solicited local reaction among vaccine rec
CDC has updated select ways to operate healthcare systems effectively in response to COVID-19 vaccination. Learn more Given new evidence on the B.1.617.2 (Delta) variant, CDC has updated the guidance for fully vaccinated people. CDC recommends universal indoor masking for all teachers, staff, students, and visitors to K-12 schools, regardless of vaccination status. Children should return to full-t
On June 27, 2024, the CDC Director adopted the ACIP’s recommendations for use of 2024–2025 COVID-19 vaccines in people ages 6 months and older as approved or authorized by FDA. The 2024–2025 vaccines are expected to be available in fall 2024. This page will be updated at that time to align with the new recommendations. Learn more: www.cdc.gov/media/releases/2024/s-t0627-vaccine-recommendations.htm
Universal masking is one of the prevention strategies recommended by CDC to slow the spread of SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19) (1). As of February 1, 2021, start highlight38end highlight states and the District of Columbia had universal masking mandates. Mask wearing has also been mandated by executive order for federal property* as well as on domestic and int
As of January 3, 2021, a total of 20,346,372 cases of coronavirus disease 2019 (COVID-19) and 349,246 associated deaths have been reported in the United States. Long-term sequalae of COVID-19 over the course of a lifetime currently are unknown; however, persistent symptoms and serious complications are being reported among COVID-19 survivors, including persons who initially experience a mild acute
As of October 15, 216,025 deaths from coronavirus disease 2019 (COVID-19) have been reported in the United States*; however, this number might underestimate the total impact of the pandemic on mortality. Measures of excess deaths have been used to estimate the impact of public health pandemics or disasters, particularly when there are questions about underascertainment of deaths directly attributa
NOTICE: THIS WEBSITE WAS ARCHIVED ON SEPTEMBER 27, 2023. Datasets linked on this page are available on data.cdc.gov. Please note that these datasets will no longer be updated after September 27, 2023. Provisional data is available on CDC WONDER (wonder.cdc.gov). Data are updated weekly, and users can query data by a variety of demographic, geographic, and temporal options. Please direct questions
The Infection Fatality Ratio (IFR) parameter has been updated to reflect recently published estimates. This parameter is now presented as the number of deaths per 1,000,000 infections for ease of interpretation. The healthcare utilization statistics in Table 2 have been updated to include a 0–17-years-old age group. This will be the final update to the COVID-19 Pandemic Planning Scenarios, as ther
COVID-19 spreads when an infected person breathes out droplets and very small particles that contain the virus. These droplets and particles can be breathed in by other people or land on their eyes, noses, or mouth. In some circumstances, they may contaminate surfaces they touch. Many viruses are constantly changing, including the virus that causes COVID-19. These changes occur over time and can l
Note: Provisional death counts are based on death certificate data received and coded by the National Center for Health Statistics as of May 9, 2024. Death counts are delayed and may differ from other published sources (see Technical Notes). Counts will be updated Thursdays by 5pm. The provisional counts for COVID-19 deaths are based on a current flow of mortality data in the National Vital Statis
Situational update as of May 2021: The supply and availability of NIOSH-approved respirators have increased significantly over the last several months. Healthcare facilities should not be using crisis capacity strategies at this time and should promptly resume conventional practices. Check the NIOSH Certified Equipment List to identify all NIOSH-approved respirators. Healthcare facilities should s
次のページ
このページを最初にブックマークしてみませんか？
『Centers for Disease Control and Prevention』の新着エントリーを見る
j次のブックマーク
k前のブックマーク
lあとで読む
eコメント一覧を開く
oページを開く
